{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:53Z","timestamp":1789474613033,"version":"build-2803163510"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117793","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:33:35Z","timestamp":1770856415000},"page":"117793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["5-Fluorouracil-induced intestinal mucositis: Pathogenesis and potential therapeutic interventions"],"prefix":"10.1016","volume":"247","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-4171","authenticated-orcid":false,"given":"Sen-lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-chun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-4764","authenticated-orcid":false,"given":"Cheng-liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1006416410198","article-title":"5-Fluorouracil: forty-plus and still ticking. a review of its preclinical and clinical development","volume":"18","author":"Grem","year":"2000","journal-title":"Invest. New Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.bcp.2026.117793_b0015","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2006.09.0928","volume":"25","author":"Falcone","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"32","key":"10.1016\/j.bcp.2026.117793_b0020","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1200\/JCO.2016.68.5776","article-title":"PANCREOX: a Randomized phase III Study of Fluorouracil\/Leucovorin with or without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in patients who have Received Gemcitabine-based Chemotherapy","volume":"34","author":"Gill","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.bcp.2026.117793_b0025","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1200\/JCO.2018.78.9636","article-title":"Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update","volume":"36","author":"Sohal","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ghir.2004.12.002","article-title":"Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats","volume":"15","author":"Cool","year":"2005","journal-title":"Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society"},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bcpt.12841","article-title":"Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model","volume":"121","author":"Liu","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12885-021-08031-z","volume":"21","author":"Janssen","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.117793_b0045","doi-asserted-by":"crossref","unstructured":"Decker-Baumann C, Buhl K, Frohmuller S, von Herbay A, Dueck M, Schlag PM. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. European journal of cancer (Oxford, England : 1990) 1999; 35(2):202-207.","DOI":"10.1016\/S0959-8049(98)00389-X"},{"key":"10.1016\/j.bcp.2026.117793_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0055","doi-asserted-by":"crossref","unstructured":"Bossi P, Antonuzzo A, Cherny NI, Rosengarten O, Pernot S, Trippa F, et al. Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29(Suppl 4):iv126-iv142. https:\/\/doi.org\/10.1093\/annonc\/mdy145.","DOI":"10.1093\/annonc\/mdy145"},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0060","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00280-016-3139-y","article-title":"Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives","volume":"78","author":"Ribeiro","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-015-0474-9","article-title":"Management of Mucositis during Chemotherapy: from Pathophysiology to Pragmatic Therapeutics","volume":"17","author":"Van Sebille","year":"2015","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","article-title":"The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs","volume":"33","author":"Logan","year":"2007","journal-title":"Cancer Treat. Rev."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2026.117793_b0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tox.2005.09.017","article-title":"Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs","volume":"217","author":"Moriyama","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2026.117793_b0080","article-title":"Characterization of a novel dual murine model of chemotherapy-induced oral and intestinal mucositis","volume":"13(1):1396","author":"Mohammed","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117793_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","article-title":"Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota","volume":"80","author":"Sougiannis","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0090","first-page":"6","volume":"22","author":"Hsu","year":"2020","journal-title":"Efficacy and Safety of High-Dose Vs Low-Dose Leucovorin in Patients with Colorectal Cancer: Systematic Review and Meta-Analysis."},{"issue":"20","key":"10.1016\/j.bcp.2026.117793_b0095","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.2010.33.5281","article-title":"Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials","volume":"29","author":"Blanke","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1200\/JCO.2002.20.6.1491","article-title":"Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer","volume":"20","author":"Sloan","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/07357909909021422","article-title":"Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency","volume":"17","author":"Shehata","year":"1999","journal-title":"Cancer Invest."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00280-017-3478-3","article-title":"DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer","volume":"81","author":"Nahid","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"35","key":"10.1016\/j.bcp.2026.117793_b0115","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1200\/JCO.22.02780","article-title":"Survival of patients with Cancer with DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-a Matched-Pair Analysis","volume":"41","author":"Knikman","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4251\/wjgo.v12.i3.332","article-title":"FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: a population-based cohort study","volume":"12","author":"Vienot","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ncponc1137","article-title":"Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer","volume":"5","author":"Vincenzi","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1758834009355164","article-title":"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management","volume":"2","author":"Stein","year":"2010","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"29","key":"10.1016\/j.bcp.2026.117793_b0135","doi-asserted-by":"crossref","first-page":"45513","DOI":"10.18632\/oncotarget.9995","article-title":"Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: an updated systematic review and meta-analysis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117793_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108689","article-title":"Vitamins and fatty acids against chemotherapy-induced intestinal mucositis","volume":"261","author":"Alcorta","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114644","article-title":"Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation","volume":"162","author":"Dahlgren","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00280-008-0715-9","article-title":"Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution","volume":"63","author":"Soares","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054788","article-title":"5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines","volume":"8","author":"Sakai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117793_b0160","article-title":"Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota","volume":"124","author":"Chen","year":"2020","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117793_b0165","doi-asserted-by":"crossref","unstructured":"Araujo CV, Lazzarotto CR, Aquino CC, Figueiredo IL, Costa TB, Alves LA, et al. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2015; 48(6):493-501. https:\/\/doi.org\/10.1590\/1414-431x20144360.","DOI":"10.1590\/1414-431x20144360"},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0170","doi-asserted-by":"crossref","first-page":"G1133","DOI":"10.1152\/ajpgi.00535.2011","article-title":"Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice","volume":"302","author":"Yasuda","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0175","first-page":"79","article-title":"Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons","volume":"68","author":"Sano","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.phrs.2014.05.012","article-title":"Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon","volume":"87","author":"Sakai","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jcmgh.2021.09.015","article-title":"2'-Fucosyllactose Ameliorates Chemotherapy-Induced Intestinal Mucositis by Protecting Intestinal Epithelial Cells against Apoptosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0190","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1073\/pnas.94.5.1795","article-title":"Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation","volume":"94","author":"Pritchard","year":"1997","journal-title":"PNAS"},{"issue":"51","key":"10.1016\/j.bcp.2026.117793_b0195","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1038\/sj.onc.1203150","article-title":"Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo","volume":"18","author":"Pritchard","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bjc.1987.25","article-title":"Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents","volume":"55","author":"Ijiri","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0205","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/bph.12019","article-title":"5-HT(3) receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells","volume":"168","author":"Yasuda","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2026.117793_b0210","first-page":"5453","article-title":"The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia","volume":"58","author":"Pritchard","year":"1998","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2026.117793_b0215","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41556-024-01550-4","article-title":"Chromatin remodelling in damaged intestinal crypts orchestrates redundant TGFbeta and Hippo signalling to drive regeneration","volume":"26","author":"Fink","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0220","first-page":"4389","article-title":"The importance of p53-independent apoptosis in the intestinal toxicity induced by raltitrexed (ZD1694, Tomudex): genetic differences between BALB\/c and DBA\/2 mice","volume":"6","author":"Pritchard","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0225","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.nut.2004.06.016","article-title":"Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice","volume":"20","author":"Carneiro-Filho","year":"2004","journal-title":"Nutrition (burbank, Los Angeles County, Calif)"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2026.117793_b0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-4274(02)00204-7","article-title":"5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia?","volume":"133","author":"Inomata","year":"2002","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0235","first-page":"1323","article-title":"Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2","volume":"145","author":"Krajewski","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2026.117793_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117612","article-title":"Protective effect of Andrographolide on 5-Fu induced intestinal mucositis by regulating p38 MAPK signaling pathway","author":"Xiang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117793_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110753","article-title":"Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress","volume":"123","author":"He","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"21","key":"10.1016\/j.bcp.2026.117793_b0250","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1111\/bph.13725","article-title":"5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1","volume":"174","author":"Altieri","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0255","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0260","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2026.117793_b0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2021.11.008","article-title":"Role of AMPK mediated pathways in autophagy and aging","volume":"195","author":"Ge","year":"2022","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.bcp.2026.117793_b0270","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.18632\/aging.101714","article-title":"Exercise training augments Sirt1-signaling and attenuates cardiac inflammation in D-galactose induced-aging rats","volume":"10","author":"Chen","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2026.117793_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117982","article-title":"Chlorogenic acid attenuates 5-fluorouracil-induced intestinal mucositis in mice through SIRT1 signaling-mediated oxidative stress and inflammatory pathways","volume":"186","author":"Lin","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073367","article-title":"Therapeutic potential for Regulation of the Nuclear factor Kappa-B Transcription factor p65 to prevent Cellular Senescence and Activation of Pro-Inflammatory in Mesenchymal Stem Cells","volume":"22","author":"Mato-Basalo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117793_b0285","article-title":"Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy","volume":"121","author":"Xia","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0290","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/gerona\/glz263","article-title":"Aging increases the Severity of Colitis and the Related changes to the Gut Barrier and Gut Microbiota in Humans and mice","volume":"75","author":"Liu","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0295","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/gerona\/glab002","article-title":"Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged mice","volume":"76","author":"Saccon","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0300","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14188","article-title":"Endoplasmic reticulum stress in the pathogenesis of chemotherapy-induced mucositis: Physiological mechanisms and therapeutic implications","volume":"240","author":"Heindryckx","year":"2024","journal-title":"Acta Physiol (Oxf.)"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1248\/bpb.b14-00400","article-title":"Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model","volume":"38","author":"Kim","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0310","first-page":"181","volume":"12","author":"Chen","year":"1997","journal-title":"Neutrophil Infiltration Is Involved in 5-Fluorouracil Induced Lipid Peroxidative Damage of the Small Intestine. Chinese Medical Sciences Journal = Chung-Kuo i Hsueh K'o Hsueh Tsa Chih"},{"issue":"12","key":"10.1016\/j.bcp.2026.117793_b0315","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/0960327115627686","article-title":"Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice","volume":"35","author":"Gou","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bcp.2026.117793_b0320","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7255497","article-title":"The Intestinal Redox System and its significance in Chemotherapy-Induced Intestinal Mucositis","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.117793_b0325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/ars.2005.7.726","article-title":"Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK","volume":"7","author":"Cakir","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.15430\/JCP.2013.18.4.322","article-title":"5-Fluorouracil-induced changes of intestinal integrity biomarkers in BALB\/c mice","volume":"18","author":"Song","year":"2013","journal-title":"Journal of Cancer Prevention"},{"key":"10.1016\/j.bcp.2026.117793_b0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4419-6612-4_32","article-title":"The TWEAK\/Fn14 pathway in tissue remodeling: for better or for worse","volume":"691","author":"Burkly","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2026.117793_b0340","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v23.i13.2294","article-title":"Disruption of the TWEAK\/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice","volume":"23","author":"Sezaki","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.117793_b0345","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nut.2016.05.003","article-title":"Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats","volume":"33","author":"Tang","year":"2017","journal-title":"Nutrition (burbank, Los Angeles County, Calif)"},{"key":"10.1016\/j.bcp.2026.117793_b0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcimb.2015.00026","article-title":"Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria","volume":"5","author":"Yu","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0355","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ibd.20142","article-title":"Activation of toll-like receptor 3 protects against DSS-induced acute colitis","volume":"13","author":"Vijay-Kumar","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0360","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00280-009-1224-1","article-title":"Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice","volume":"66","author":"Letari","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111887","article-title":"Ameliorative effect of Atractylodes macrocephala essential oil combined with Panax ginseng total saponins on 5-fluorouracil induced diarrhea is associated with gut microbial modulation","volume":"238","author":"Wang","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0370","article-title":"Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117793_b0375","first-page":"1","article-title":"NOD-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Activation Exacerbates 5-Fluorouracil-Induced Small Intestinal Mucositis via Interleukin-1beta Activation","author":"Nakata","year":"2019","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0380","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000504974","article-title":"NOD-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Activation Exacerbates 5-Fluorouracil-Induced Small Intestinal Mucositis via Interleukin-1\u03b2 Activation","volume":"102","author":"Nakata","year":"2021","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0385","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/bcpt.12619","article-title":"Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development","volume":"119","author":"Sakai","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0390","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4161\/cbt.29114","article-title":"Activation of p38-MAPK by CXCL4\/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil","volume":"15","author":"Gao","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0395","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3068393","article-title":"Immune Modulation Effects of Lactobacillus casei Variety rhamnosus on Enterocytes and Intestinal Stem Cells in a 5-FU-Induced Mucositis Mouse Model","volume":"2021","author":"Yeung","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"issue":"24","key":"10.1016\/j.bcp.2026.117793_b0400","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1111\/bph.13646","article-title":"Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice","volume":"173","author":"McQuade","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0405","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fnins.2019.00449","article-title":"Co-treatment with BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction","volume":"13","author":"McQuade","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0410","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bph.14883","article-title":"Isoprenaline protects intestinal stem cells from chemotherapy-induced damage","volume":"177","author":"Zeng","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0415","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphys.2018.00260","article-title":"Cholinergic Submucosal Neurons Display increased Excitability following in Vivo Cholera Toxin Exposure in Mouse Ileum","volume":"9","author":"Fung","year":"2018","journal-title":"Front. Physiol."},{"issue":"9298","key":"10.1016\/j.bcp.2026.117793_b0420","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(01)07103-3","article-title":"Serotoninergic neuroenteric modulators","volume":"358","author":"Talley","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0425","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/00365520701579662","article-title":"Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis","volume":"43","author":"Saegusa","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0430","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0016-5085(98)70585-2","article-title":"Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury","volume":"114","author":"Tanaka","year":"1998","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0435","first-page":"195","article-title":"Correlation between the histological changes and glucose intestinal absorption following a single dose of 5 fluorouracil","volume":"3","author":"Roche","year":"1970","journal-title":"Digestion"},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0440","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jps.20388","article-title":"Enhanced absorption of 3-O-methyl glucose following gastrointestinal injury induced by repeated oral administration of 5-FU in mice","volume":"94","author":"Hakata","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2005.04.001","article-title":"Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil","volume":"155","author":"Tomimatsu","year":"2005","journal-title":"Chem. Biol. Interact."},{"issue":"16","key":"10.1016\/j.bcp.2026.117793_b0450","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1074\/jbc.273.16.9510","article-title":"Circadian periodicity of intestinal Na+\/glucose cotransporter 1 mRNA levels is transcriptionally regulated","volume":"273","author":"Rhoads","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2026.117793_b0455","article-title":"An inulin-type fructan CP-A from Codonopsis pilosula combined with 5-Fluorouracil alleviates colitis-associated tumorigenesis via inhibition of EGFR\/AKT\/ERK signaling pathway and regulation of intestinal flora","volume":"308","author":"Zhou","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2026.117793_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155492","article-title":"Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0465","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4161\/cbt.11.7.14896","article-title":"Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats","volume":"11","author":"Prisciandaro","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000879","article-title":"The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis","volume":"6","author":"van Vliet","year":"2010","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0475","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.apsb.2023.12.015","article-title":"Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier","volume":"14","author":"Bai","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0480","doi-asserted-by":"crossref","DOI":"10.3390\/nu15051117","article-title":"Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model","volume":"15","author":"Jakubauskas","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0485","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/1440-1681.12792","article-title":"Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses","volume":"44","author":"Kato","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117793_b0490","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S0007114513004248","article-title":"Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice","volume":"111","author":"Justino","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bcp.2026.117793_b0495","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fmicb.2018.00983","article-title":"Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil\/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model","volume":"9","author":"Chang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0500","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.gtc.2017.08.006","article-title":"The Brain-Gut Axis and stress in Inflammatory Bowel Disease","volume":"46","author":"Bernstein","year":"2017","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.bcp.2026.117793_b0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejphar.2018.12.014","article-title":"Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents","volume":"843","author":"Atiq","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0510","article-title":"Gerling M","volume":"4","author":"Kordes","year":"2019","journal-title":"Variations in the Management of Diarrhoea Induced by Cancer Therapy: Results from an International, Cross-Sectional Survey among European Oncologists."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0515","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CAD.0000000000000142","article-title":"Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis","volume":"26","author":"Wang","year":"2015","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0520","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231544","article-title":"Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide","volume":"12","author":"Shumar","year":"2019","journal-title":"BMJ Case Reports"},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0525","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(14)70006-3","article-title":"Guidance on the management of diarrhoea during cancer chemotherapy","volume":"15","author":"Andreyev","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0530","first-page":"1057","article-title":"Influence of androgen on myocardial apoptosis and expression of myocardial IR and IRS\u20111 in chronic heart failure rat models","volume":"17","author":"Wang","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0535","article-title":"Therapeutic proposals that Improve Morphological changes of 5-Fluorouracil-Induced Intestinal Mucositis: a Review of the Literature. Journal of Morphological","volume":"38","author":"Barbosa","year":"2021","journal-title":"Sciences"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0540","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1470-2045(05)01735-3","article-title":"Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea","volume":"6","author":"Sharma","year":"2005","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0545","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1078155207077335","article-title":"Chemotherapy induced diarrhea","volume":"13","author":"Richardson","year":"2007","journal-title":"Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0550","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpainsymman.2011.06.001","article-title":"Loperamide","volume":"42","author":"Regnard","year":"2011","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.bcp.2026.117793_b0555","unstructured":"Saltz LB. Understanding and managing chemotherapy-induced diarrhea. The journal of supportive oncology 2003; 1(1):35-46; discussion 38-41, 45-36."},{"issue":"14","key":"10.1016\/j.bcp.2026.117793_b0560","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","article-title":"Recommended guidelines for the treatment of cancer treatment-induced diarrhea","volume":"22","author":"Benson","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0565","first-page":"65","article-title":"High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients","volume":"8","author":"Cascinu","year":"2000","journal-title":"Support Care Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2026.117793_b0570","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jacc.2023.06.054","article-title":"Loperamide-Associated Ventricular Arrhythmias","volume":"82","author":"Font","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2026.117793_b0575","article-title":"Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Annals of oncology : official journal of the European Society for","volume":"19 Suppl 2","author":"Peterson","year":"2008","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0580","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/ajco.12055","article-title":"Role of octreotide in post chemotherapy and\/or radiotherapy diarrhea: prophylaxis or therapy?","volume":"10","author":"Sun","year":"2014","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/pbc.22838","article-title":"Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease","volume":"56","author":"Pai","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcp.2026.117793_b0590","article-title":"Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept","author":"Vdh","year":"2016","journal-title":"Minerva Chir."},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0595","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1200\/JCO.2013.50.8077","article-title":"Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial","volume":"32","author":"Hoff","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0600","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnci\/djq063","article-title":"Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315","volume":"102","author":"Zachariah","year":"2010","journal-title":"J. Natl Cancer Inst."},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0605","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1023\/A:1008390308416","article-title":"Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment","volume":"10","author":"Lenfers","year":"1999","journal-title":"Annals of Oncology : Official Journal of the European Society for Medical Oncology"},{"issue":"4\u20136","key":"10.1016\/j.bcp.2026.117793_b0610","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000086971","article-title":"Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer","volume":"68","author":"Karthaus","year":"2005","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0615","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/annonc\/mdg193","article-title":"Prevention of irinotecan plus 5-fluorouracil\/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer","volume":"14","author":"Alimonti","year":"2003","journal-title":"Annals of Oncology : Official Journal of the European Society for Medical Oncology"},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0620","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/gutjnl-2012-303184","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach","volume":"62","author":"Perez-Cobas","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2026.117793_b0625","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2014.06.010","article-title":"Community-acquired diarrhea associated with Clostridium difficile in an HIV-positive cancer patient: first case report in Latin America","volume":"26","author":"Costa","year":"2014","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0630","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.30321","article-title":"Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity","volume":"123","author":"Ma","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0635","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bcp.16319","article-title":"Review of the fluoropyrimidine antidote uridine triacetate","volume":"91","author":"Thompson","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2026.117793_b0640","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1158\/1078-0432.CCR-16-0638","article-title":"FDA Approval: Uridine Triacetate for the Treatment of patients following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities following Administration of these Drugs","volume":"22","author":"Ison","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0645","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbrc.2009.09.041","article-title":"Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model","volume":"389","author":"Huang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0650","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12866-024-03384-4","article-title":"Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon","volume":"24","author":"Ziemons","year":"2024","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bcp.2026.117793_b0655","article-title":"Pediococcus pentosaceus PP34 Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis via Inhibiting Oxidative stress and Restoring the Gut Microbiota","author":"He","year":"2024","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.bcp.2026.117793_b0660","doi-asserted-by":"crossref","DOI":"10.1007\/s12223-025-01310-3","article-title":"Prophylactic and therapeutic effects of Limosilactobacillus reuteri E on 5-fluorouracil-induced intestinal mucositis in Caco-2 cells","author":"Hlubinova","year":"2025","journal-title":"Folia Microbiol. (Praha)"},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0665","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12602-021-09817-0","article-title":"Antarctic Strain of Rhodotorula mucilaginosa UFMGCB 18,377 Attenuates Mucositis Induced by 5-Fluorouracil in mice","volume":"14","author":"Coutinho","year":"2022","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.bcp.2026.117793_b0670","doi-asserted-by":"crossref","DOI":"10.1111\/all.13495","article-title":"Probiotics for the airways: potential to improve epithelial and immune homeostasis","author":"Martens","year":"2018","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0675","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603990","article-title":"Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study","volume":"97","author":"Osterlund","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0680","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12602-022-09978-6","article-title":"Evaluation of Probiotic Properties of Novel Brazilian Lactiplantibacillus plantarum Strains","volume":"15","author":"Coelho-Rocha","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.bcp.2026.117793_b0685","doi-asserted-by":"crossref","unstructured":"138. de Assis Gloria R, da Silva TF, Gomes TAM, Vital KD, Fernandes SOA, Cardoso VN, et al. Postbiotic Effect of Escherichia coli CEC15 and Escherichia coli Nissle 1917 on a Murine Model of 5-FU-induced Intestinal Mucositis. Probiotics Antimicrob Proteins 2024. https:\/\/doi.org\/10.1007\/s12602-024-10414-0.","DOI":"10.1007\/s12602-024-10414-0"},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0690","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10620-006-9464-y","article-title":"Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats","volume":"52","author":"Mauger","year":"2007","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0695","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2355693","article-title":"Dietary restriction rescues 5-fluorouracil-induced lethal intestinal toxicity in old mice by blocking translocation of opportunistic pathogens","volume":"16","author":"Tang","year":"2024","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0700","first-page":"1609","article-title":"Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon","volume":"24","author":"Kawashima","year":"2016","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0705","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00795-013-0055-7","article-title":"Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats","volume":"47","author":"Fukudome","year":"2014","journal-title":"Med. Mol. Morphol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0710","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00042737-200405000-00008","article-title":"Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat","volume":"16","author":"Gomez de Segura","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00795-013-0012-5","article-title":"Effects of a water-soluble extract of Ganoderma lucidum mycelia on aberrant crypt foci induced by azoxymethane and small-intestinal injury by 5-FU in F344 rats","volume":"46","author":"Watanabe","year":"2013","journal-title":"Med. Mol. Morphol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0720","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clnu.2007.12.004","article-title":"Fish oil infusion reverses 5-fluorouracil-induced impairments in mucosal immunity in mice","volume":"27","author":"Fukatsu","year":"2008","journal-title":"Clinical Nutrition (edinburgh, Scotland)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10620-008-0325-8","article-title":"Impairment by 5-fluorouracil of the healing of gastric lesions in rats: effect of lafutidine, a histamine H2 receptor antagonist, mediated by capsaicin-sensitive afferent neurons","volume":"54","author":"Murashima","year":"2009","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0730","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00365520701811693","article-title":"Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis","volume":"43","author":"Saegusa","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0735","first-page":"933","article-title":"Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality","volume":"58","author":"Farrell","year":"1998","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0740","first-page":"49","article-title":"Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats","volume":"17","author":"Petschow","year":"1993","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0745","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0030-4220(92)90402-C","article-title":"Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy","volume":"74","author":"Sonis","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0750","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0964-1955(95)00015-A","article-title":"Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11","volume":"31B","author":"Sonis","year":"1995","journal-title":"Eur. J. Cancer B Oral Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117793_b0755","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/cyto.1997.0208","article-title":"Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters","volume":"9","author":"Sonis","year":"1997","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0760","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jss.2005.04.037","article-title":"The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats","volume":"128","author":"Kucuk","year":"2005","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0765","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MOG.0b013e32835004c6","article-title":"Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors","volume":"28","author":"Bortvedt","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0770","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1023\/A:1015010728696","article-title":"Insulin-like growth factor-I stimulates Na+-dependent glutamine absorption in piglet enterocytes","volume":"47","author":"Alexander","year":"2002","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0775","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s10620-008-0215-0","article-title":"Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro","volume":"53","author":"Braga-Neto","year":"2008","journal-title":"Dig. Dis. Sci."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2026.117793_b0780","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2004.02.019","article-title":"The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight","volume":"488","author":"Yamazaki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117793_b0785","first-page":"1759","article-title":"Glucagon-like peptide 2","volume":"86","author":"Drucker","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b0790","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s11033-022-07384-3","article-title":"Possible cytoprotective mechanisms of oxytocin against 5-fluorouracil-induced gastrointestinal mucositis","volume":"49","author":"Chukwunyere","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2026.117793_b0795","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jep.2016.05.057","article-title":"Protective effect and potential mechanisms of Wei-Chang-an pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice","volume":"190","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0800","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3389\/fphar.2017.00786","article-title":"Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositis","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117793_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112519","article-title":"Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport","volume":"250","author":"Gan","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0810","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13568-024-01796-z","article-title":"Lentinan's effect on gut microbiota and inflammatory cytokines in 5-FU-induced mucositis mice","volume":"15","author":"Zhang","year":"2025","journal-title":"AMB Express"},{"issue":"23","key":"10.1016\/j.bcp.2026.117793_b0815","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313085","article-title":"Ameliorative effect of Ginsenoside Rc on 5-Fluorouracil-Induced Chemotherapeutic Intestinal Mucositis via the PI3K-AKT\/NF-kappaB Signaling Pathway: In Vivo and In Vitro evaluations","volume":"25","author":"Xu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bcp.2026.117793_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34528","article-title":"Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0825","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/0115672018304338241003095955","article-title":"Fecal Microbiota Transplantation Induced by Wumei Pills Improves Chemotherapy-Induced Intestinal Mucositis in BALB\/c mice by Modulating the TLR4\/MyD88\/NF-kappaB Signaling Pathway","volume":"22","author":"Lu","year":"2025","journal-title":"Curr. Drug Deliv."},{"issue":"9","key":"10.1016\/j.bcp.2026.117793_b0830","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1002\/fsn3.4283","article-title":"Fig seed oil improves intestinal damage caused by 5-FU-induced mucositis in rats","volume":"12","author":"Alan","year":"2024","journal-title":"Food Sci. Nutr."},{"issue":"9","key":"10.1016\/j.bcp.2026.117793_b0835","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23405","article-title":"Thymoquinone protects against 5-Fluorouracil-induced mucositis by NF-kappabeta and HIF-1 mechanisms in mice","volume":"37","author":"Madani","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bcp.2026.117793_b0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117612","article-title":"Protective effect of Andrographolide on 5-Fu induced intestinal mucositis by regulating p38 MAPK signaling pathway","volume":"252","author":"Xiang","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0845","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.121.000677","article-title":"Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in mice by Inhibiting JAKs","volume":"379","author":"Wang","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0850","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.2147\/DDDT.S515605","article-title":"Mechanisms of Magnoliae Officinalis Cortex Volatile Oil in Alleviating 5-Fluorouracil-Induced Mucositis via Multi-Omics Approaches","volume":"19","author":"Zhang","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119616","article-title":"Exploring dried ginger essential oil as a therapeutic strategy for 5-FU-induced mucositis: Gut microbiota and tryptophan metabolite IAA-AHR\/IL-22\/STAT3 signaling axis","volume":"345","author":"Zhao","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0860","doi-asserted-by":"crossref","first-page":"21852","DOI":"10.1038\/s41598-024-72536-3","article-title":"Oleanolic acid improves 5-fluorouracil-induced intestinal damage and inflammation by alleviating intestinal senescence","volume":"14","author":"Bai","year":"2024","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2026.117793_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103666","article-title":"Network pharmacology and experimental validation reveal that betulin alleviates 5-fluorouracil-induced intestinal injury by inhibiting intestinal senescence and enhances antitumor efficacy","volume":"392","author":"Wang","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.117793_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156843","article-title":"Pectolinarigenin mitigates 5-FU-induced intestinal mucositis via suppressing ferroptosis through activating PPARgamma\/GPX4 signaling","volume":"143","author":"Ge","year":"2025","journal-title":"Phytomedicine"},{"issue":"41","key":"10.1016\/j.bcp.2026.117793_b0875","doi-asserted-by":"crossref","first-page":"15156","DOI":"10.1021\/acs.jafc.3c05051","article-title":"Alpinia katsumadai Hayata Volatile Oil is Effective in Treating 5-Fluorouracil-Induced Mucositis by Regulating Gut Microbiota and Modulating the GC\/GR Pathway and the mPGES-1\/PGE2\/EP4 Pathways","volume":"71","author":"Liu","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.117793_b0880","article-title":"Protective Effects of Alpha-Lipoic Acid against 5-Fluorouracil-Induced Gastrointestinal Mucositis in Rats","volume":"11","author":"Ceylanli","year":"2022","journal-title":"Antioxidants (basel)"},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0885","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41401-019-0295-8","article-title":"A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice","volume":"41","author":"Yan","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0890","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s11658-021-00294-5","article-title":"TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2","volume":"26","author":"Deng","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bcp.2026.117793_b0895","article-title":"Losartan improves intestinal mucositis induced by 5-fluorouracil in mice","volume":"11(1):23241","author":"Oliveira","year":"2021","journal-title":"Sci. Rep."},{"issue":"Pt A","key":"10.1016\/j.bcp.2026.117793_b0900","article-title":"Metformin ameliorates 5-fluorouracil-induced intestinalinjury by inhibiting cellular senescence, inflammation, and oxidative stress","volume":"113","author":"Xia","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117793_b0905","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.curtheres.2011.11.003","article-title":"In vivo effects of immunomodulators in a murine model of Fluorouracil-induced mucositis","volume":"72","author":"Tung","year":"2011","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.bcp.2026.117793_b0910","article-title":"Pharmacokinetics-based Dose Management of 5-Fluorouracil Clinical Research in Advanced Colorectal Cancer Treatment","author":"Deng","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0915","first-page":"1485","article-title":"The Superoxide Dismutase Mimetic M40403, Improves 5-Fluorouracil-induced Small Intestinal Mucositis in a Mouse Model","volume":"35","author":"Yim","year":"2021","journal-title":"In Vivo (athens, Greece)"},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0920","first-page":"203","article-title":"Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens","volume":"10","author":"Saam","year":"2011","journal-title":"Clin. Colorectal Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2026.117793_b0925","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11095-018-2457-7","article-title":"Evaluation of Antiproliferative activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study","volume":"35","author":"Ahmed","year":"2018","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0930","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FTD.0000000000000238","article-title":"Individual 5-Fluorouracil Dose Adjustment via Pharmacokinetic monitoring Versus conventional Body-Area-Surface Method: a Meta-Analysis","volume":"38","author":"Yang","year":"2016","journal-title":"Ther. Drug Monit."},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0940","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10071418","article-title":"Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation","volume":"10","author":"Batista","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.bcp.2026.117793_b0945","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2022.04.135","article-title":"Akkermansia muciniphila and its outer membrane protein amuc_1100 prophylactically attenuate 5-fluorouracil-induced intestinal mucositis","volume":"614","author":"Chen","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0950","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12866-023-03112-4","article-title":"Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain","volume":"23","author":"da Silva","year":"2023","journal-title":"BMC Microbiol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117793_b0955","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121676","article-title":"Bacillus clausii Attenuates 5-Fluorouracil-Induced Intestinal Mucositis in mice","volume":"17","author":"Lima","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2026.117793_b0960","article-title":"A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice","author":"Yan","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2026.117793_b0965","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bcpt.12793","article-title":"Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in mice","volume":"121","author":"Hamouda","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0970","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/1535370213493718","article-title":"Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats","volume":"238","author":"Mashtoub","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"11","key":"10.1016\/j.bcp.2026.117793_b0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225389","article-title":"Nutritional treatment with an immune-modulating enteral formula alleviates 5-fluorouracil-induced adverse effects in rats","volume":"14","author":"Nakamura","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2026.117793_b0980","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.joim.2020.12.004","article-title":"Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis","volume":"19","author":"Li","year":"2021","journal-title":"J Integr Med"},{"issue":"7","key":"10.1016\/j.bcp.2026.117793_b0985","doi-asserted-by":"crossref","first-page":"98806","DOI":"10.3748\/wjg.v31.i7.98806","article-title":"Modified Pulsatilla decoction alleviates 5-fluorouracil-induced intestinal mucositis by modulating the TLR4\/MyD88\/NF-kappaB pathway and gut microbiota","volume":"31","author":"Qiu","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0990","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22932","article-title":"Thymol ameliorates 5-fluorouracil-induced intestinal mucositis: evidence of down-regulatory effect on TGF-beta\/MAPK pathways through NF-kappaB","volume":"36","author":"Al-Khrashi","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0995","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12672-023-00747-7","article-title":"Artesunate alleviates 5-fluorouracil-induced intestinal damage by suppressing cellular senescence and enhances its antitumor activity","volume":"14","author":"Xia","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bcp.2026.117793_b1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154092","article-title":"Protective role of casuarinin from Melastoma malabathricum against a mouse model of 5-fluorouracil-induced intestinal mucositis: Impact on inflammation and gut microbiota dysbiosis","volume":"101","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.117793_b1005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1526274","article-title":"Bletilla oligosaccharides improved 5-fluorouracil-induced intestinal mucositis in mice by activating NF-kappaB signalling pathway and regulating intestinal microbiota","volume":"16","author":"Yin","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2026.117793_b1010","article-title":"Alginate oligosaccharide improves 5-fluorouracil-induced intestinal mucositis by enhancing intestinal barrier and modulating intestinal levels of butyrate and isovalerate","volume":"276","author":"Teng","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2026.117793_b1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117545","article-title":"Oyster polysaccharides ameliorate intestinal mucositis and improve metabolism in 5-fluorouracil-treated S180 tumour-bearing mice","volume":"256","author":"Cai","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bcp.2026.117793_b1020","article-title":"Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the mice Model","volume":"2022","author":"Huang","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116213","article-title":"Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells","volume":"10","author":"Kato","year":"2015","journal-title":"PLoS One"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.117793_b1030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2152\/jmi.57.314","article-title":"Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury","volume":"57","author":"Shiota","year":"2010","journal-title":"The Journal of Medical Investigation : JMI"},{"key":"10.1016\/j.bcp.2026.117793_b1035","article-title":"Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2\/MyD88\/NF-kB pathway and regulation of microbiota","volume":"124","author":"Wu","year":"2020","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2026.117793_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116888","article-title":"Mucoprotective effects of Saikosaponin-a in 5-fluorouracil-induced intestinal mucositis in mice model","volume":"239","author":"Ali","year":"2019","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b1045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biopha.2011.04.013","article-title":"Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model","volume":"65","author":"Wu","year":"2011","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"5","key":"10.1016\/j.bcp.2026.117793_b1050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1208\/s12249-021-01941-y","article-title":"Oral Administration of Melatonin or Succinyl Melatonin Niosome Gel Benefits 5-FU-Induced Small Intestinal Mucositis Treatment in mice","volume":"22","author":"Uthaiwat","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bcp.2026.117793_b1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117404","article-title":"Experimental and network pharmacology certify itraconazole mitigates fluorouracil-induced intestinal damage by inhibiting mTOR-mediated intestinal senescence","volume":"502","author":"Ge","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b1060","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1038\/s41598-024-66771-x","article-title":"Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory","volume":"14","author":"He","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.117793_b0935","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13287-024-03738-9","article-title":"Mesenchymal stromal\/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage","volume":"15","author":"Yetkin-Arik","year":"2024","journal-title":"Stem Cell Res Ther"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:06:18Z","timestamp":1779109578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":212,"alternative-id":["S0006295226001243"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117793","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Fluorouracil-induced intestinal mucositis: Pathogenesis and potential therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117793"}}